The global Lab Automation Market is valued at USD 5.3 Billion in 2022 and is projected to reach a value of USD 8.97 Billion by 2030 at a CAGR (Compound Annual Growth Rate) of 6.8% between 2023 and 2030.
Leading the Lab Automation market forward is the growing demand for expedited research and development procedures. Recent data from credible sources such as the International Society for Automation (ISA) and industry studies indicates that the Lab Automation market has been growing at a strong rate, with an estimated compound annual growth rate (CAGR) of about 6-8% over the last few years. This expansion is the result of multiple important factors. First, the adoption of Lab Automation systems has been further accelerated by the growing need for high-throughput screening in the biotechnology and pharmaceutical industries, which is driven by the desire for speedier drug discovery and development. Furthermore, workflows in laboratories have been completely transformed by advances in robots and artificial intelligence (AI), which have reduced human mistake rates and increased efficiency. Furthermore, the necessity of Lab Automation is further highlighted by the growing focus on cost reduction and improved data accuracy in a variety of industries, including materials research, healthcare, and agriculture.
Lab Automation Market Size, 2022 To 2030 (USD Billion)
- The need for increased efficiency, accuracy, and reproducibility in laboratory processes, as well as the demand for high-throughput screening and analysis, is driving the global Lab Automation market during the projection period from 2023 to 2030.
- The continuous flow equipment will continue to assert its dominance by process, capturing the largest market share globally throughout the forecast period 2023 to 2030.
- In 2022, North America exhibited its market prowess, achieving the highest revenue share of over 42%.
- The Asia Pacific region is poised for remarkable growth, displaying a noteworthy Compound Annual Growth Rate (CAGR) between 2023 and 2030.
Top Market Trends
- The integration of artificial intelligence (AI) and machine learning (ML) algorithms into laboratory processes is a notable trend observed in the Lab Automation market. Predictive analytics are made possible, workflows are optimized, and decision-making skills are improved.
- The growing use of robotic systems in laboratories is leading to an increase in automation. These robots can reduce human error by performing repetitive tasks with consistency and precision, such as handling and preparing samples.
- Solutions for remote monitoring and control are becoming more and more in demand. IoT technology is being used in labs to remotely control equipment and track experiments in real-time, increasing accessibility and efficiency.
- Large volumes of data are being produced by Lab Automation. Trend analysis and data-driven insights are increasingly important for process optimization, compliance, and advancing scientific discoveries.
- Customization and scalability are becoming priorities in the design of Lab Automation solutions. This makes it possible for labs to easily expand or change automation systems as needed to meet changing requirements.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
The Lab Automation Market has been significantly shaped by economic insights, especially in light of the COVID-19 epidemic. The pandemic initially had a negative effect on the industry because lockdowns and supply chain issues caused interruptions in laboratories all around the world, which delayed automation initiatives. But as the need for vaccine development and diagnostic testing increased, so did the demand for Lab Automation solutions, especially in pharmaceutical research and diagnostic labs. In order to improve testing capacity and turnaround times, automated testing platforms were adopted at a significantly higher rate during the pandemic, according to research published by the American Association for Clinical Chemistry (AACC). In addition, the industry saw a shift toward automation and remote monitoring to guarantee business continuity and security, with firms such as LabWare providing solutions designed to address pandemic-related issues.
The Global Market is segregated into the segments as mentioned below:The globel Lab Automation market can be categorized into Process, Automation Type, End-Use, Region. The Market can be categorized into Continuous Flow, Discrete Processing based on Process. The Market can be categorized into Total Automation Systems, Modular Automation Systems based on Automation Type. The Market can be categorized into Photometry & Fluorometry, Immunoassay Analysis, Electrolyte Analysis, Clinical Chemistry Analysis, Other End-Uses based on End-Use. The Market can be categorized into North America, Europe, Asia Pacific, Latin America, Middle East & Africa based on Region.
Below tree is interactive. You can click the nodes to get more information.
Based on Process
Continuous Flow to Accommodate the Widest Market Share Owing to a More Effective Solution
In 2022, continuous flow is the leading product utilized in the Lab Automation Market. This is primarily due to the fact that constant flow systems provide a more efficient and streamlined method for processing laboratory duties. They are designed to accommodate a continuous influx of samples, allowing for a high-throughput workflow. This is particularly advantageous in situations where a large number of pieces must be processed quickly, such as in clinical diagnostics or high-throughput screening for drug discovery. Continuous flow systems minimize downtime between duties, reduce the need for manual intervention, and guarantee a constant and uninterrupted workflow. Discrete Processing, on the other hand, which handles individual samples one at a time, is better adapted for applications that require more customized or varied processing steps but may not match the efficiency of continuous flow systems in high-volume settings. Consequently, constant flow products are widely preferred in the Lab Automation Market due to their capacity to maximize productivity and throughput.
Based on End Use
Immunoassay Analysis to Increase Revenue Due to Essential Functionality
Immunoassay Analysis is one of the most widely utilized product on the Lab Automation Market. Its essential function in clinical diagnostics is the primary reason for its widespread use. Immunoassays are extensively used for detecting and quantifying numerous biomolecules, such as hormones, antibodies, and specific proteins, making them indispensable for diagnosing a vast array of diseases and monitoring patient health. In clinical settings where accuracy is paramount, their high sensitivity and specificity are crucial. In addition, the automation of immunoassay analysis permits laboratories to efficiently process a large number of patient samples, thereby reducing turnover times significantly. This is especially important in the medical field, where a prompt diagnosis can be vital. Consequently, Immunoassay Analysis's dominance in the Lab Automation Market is a reflection of its essential function in healthcare and diagnostics.
Based on Region
North America to Lead Global Sales Region due to an Incredibly Well-Developed Infrastructure
The Lab Automation market is associated with the highest sales in North America. Several factors, including a highly developed healthcare infrastructure, substantial investments in research and development, and a strong presence of pharmaceutical and biotechnology companies, contribute to this dominance. Demand for Lab Automation solutions is driven by the desire of the region's advanced laboratories to optimize their workflows and increase their efficacy. In addition, the COVID-19 accelerated the adoption of laboratory automation in North America, as the need for high-throughput testing and vaccine development became of the utmost importance.
The Lab Automation Market is experiencing significant growth in the Asia Pacific area. This expansion can be attributed to rising healthcare costs, an increase in clinical laboratories, and a flourishing pharmaceutical industry. In addition, emerging economies in the Asia-Pacific region are making significant investments in healthcare infrastructure and research, which is driving the adoption of Lab Automation solutions to satisfy the rising demand for advanced diagnostic and research capabilities.
The Lab Automation Market is characterized by a highly competitive landscape, with numerous major competitors contending for market share. Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are market leaders due to their extensive product lines and global presence. These industry leaders maintain their competitive advantage through continuous innovation and strategic partnerships. In addition, the number of innovative firms offering niche automation solutions is growing, intensifying competition. Market dynamics are shaped by ongoing technological advancements, customization demands, and the need for integrated systems, nurturing a competitive environment focused on delivering efficiency and precision to laboratory workflows.
The key players in the global Lab Automation market include - F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Siemens Healthcare GmbH (Germany), Danaher Corporation (U.S.), Agilent Technologies Inc. (U.S.), Eppendorf SE (Germany), Hudson Robotics (U.S.), Aurora Biomed Inc. (Canada), BMG Labtech GmbH (Germany), Tecan Trading AG (Switzerland), Hamilton Company (U.S.) among others.
Recent Market Developments
- In April 2022, small molecule discovery programs looking for a quicker, more automated method to complete Design, Make, Test, and Analyze (DMTA) cycles can now access an integrated solution from Strateos, Inc., a pioneer in the development of remote access laboratories and Lab Automation software for life science research.
- March 2022: The Green Button Go software package has various new features and products that Biosero has added. This BICO firm develops laboratory automation systems to coordinate scientific discoveries. These solutions offer cutting-edge features to assist clients in optimizing, managing, and improving the output of their automated laboratory equipment. Scientists can automate processes across many labs, or just one workstation by using Biosero's Green Button Go software.
Segmentation of the Global Lab Automation Market
- Process (Continuous Flow, Discrete Processing)
- Automation Type (Total Automation Systems, Modular Automation Systems)
- End-Use (Photometry & Fluorometry, Immunoassay Analysis, Electrolyte Analysis, Clinical Chemistry Analysis, Other End-Uses)
- Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
|Regions & Countries Covered
- North America - (U.S., Canada, Mexico)
- Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
- Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
- Latin America - (Brazil, Argentina, Rest Of Latin America)
- Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- QIAGEN (Germany)
- PerkinElmer Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Siemens Healthcare GmbH (Germany)
- Danaher Corporation (U.S.)
- Agilent Technologies Inc. (U.S.)
- Eppendorf SE (Germany)
- Hudson Robotics (U.S.)
- Aurora Biomed Inc. (Canada)
- BMG Labtech GmbH (Germany)
- Tecan Trading AG (Switzerland)
- Hamilton Company (U.S.)
||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Pricing and purchase options
||Avail of customized purchase options to meet your exact research needs. Explore purchase options